未来大流行中的疫苗接种意愿:基于情境实验的证据
该研究在匈牙利开展预注册情境实验(N=1000),通过在线调查随机呈现八种情景,考察疾病严重性、疫苗原产国、技术、监管批准、副作用和推荐来源对接种意愿的影响。多水平线性模型显示,疫苗副作用、批准状态和原产国是最强预测因素;受访者更不愿接受副作用较强或原产中国的疫苗,偏好匈牙利与欧洲当局联合批准的疫苗。疫苗技术(mRNA与非mRNA)和推荐来源无显著效应,且低教育、农村和未接种COVID-19疫苗者受疫苗属性影响较小。
要点
- 疫苗副作用、批准状态和原产国是未来大流行接种意愿的最强预测因素。
- 受访者更不愿接受副作用较强或原产中国的疫苗,偏好匈牙利与欧洲当局联合批准的疫苗。
- 低教育、农村和未接种COVID-19疫苗者对疫苗属性差异不敏感。
核心结论
- 疫苗副作用和机构合法性是未来假设大流行中接种意愿的核心关注点,技术差异作用较小。
研究设计与样本
- 在匈牙利开展预注册情境实验,在线调查N=1000,每名受访者随机评估八个情景。
- 实验操纵六个疾病与疫苗相关属性:疾病严重性、疫苗原产国、技术、监管批准、副作用和推荐来源。
- 采用多水平线性模型估计情景属性和个体特征的主效应与交互效应。
主要发现
- 疫苗副作用、批准状态和原产国是未来大流行接种意愿的最强预测因素。
- 受访者显著更不愿接受副作用较强或原产中国的疫苗。
- 受访者偏好匈牙利与欧洲当局联合批准的疫苗。
- 疫苗技术(mRNA与非mRNA)和推荐来源对接种意愿无显著影响。
- 低教育、农村和未接种COVID-19疫苗的受访者受疫苗属性或情境因素差异影响较小。
临床怎么用
- 通过透明、循证的沟通增强信任,并早期接触公众。
- 针对犹豫亚组的特定关切设计定制信息,即使这些亚组不受疾病和疫苗因素影响。
- 上述策略有助于提高疫苗接种率和大流行准备。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The COVID-19 pandemic highlighted both the importance of vaccination and the persistent challenge of vaccine hesitancy. As future global outbreaks remain a realistic threat, understanding the factors shaping vaccination intentions beyond the COVID-19 context is crucial. We conducted a pre-registered vignette experiment in an online survey in Hungary (N=1000), varying six disease and vaccine-related attributes: disease severity, vaccine's country of origin, technology, regulatory approval, side effects, and recommendation source. Respondents evaluated eight randomly assigned scenarios each. Multilevel linear models were used to estimate the main and interaction effects of vignette and individual characteristics. Vaccine side effects, approval status, and country of origin were the strongest predictors of willingness to vaccinate in a future pandemic. Respondents were substantially less willing to accept vaccines with stronger side effects or those originating from China, and preferred vaccines jointly approved by Hungarian and European authorities. In contrast, vaccine technology (mRNA vs. non-mRNA) and recommendation source had no significant effect. Less-educated, rural respondents and those unvaccinated against COVID-19 were largely unaffected by differences in vaccine attributes or contextual factors. Concerns over side effects and institutional legitimacy remain central in hypothetical future pandemics, while technological distinctions play a minor role. Strengthening trust through transparent, evidence-based communication, early engagement, and tailored messages addressing the specific concerns of hesitant subgroups not even influenced by disease and vaccine-related factors will be essential to improve vaccine uptake and pandemic preparedness.
引用
- Stefkovics Á, Ligeti AS, Koltai J, et al. Willingness to vaccinate in a future pandemic. Evidence from a vignette experiment. Vaccine. 2026. PMID: 41672033. doi:10.1016/j.vaccine.2026.128284
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。